POSTED ON April 22, 2026

The Powerful Journey From Product Selling to Value Driven Deals

In this episode of the Medical Sales Podcast, Samuel Adeyinka sits down with TJ Quigley to break down the biggest shift in medical sales: why features and benefits selling no longer works and how value driven selling wins in today’s healthcare landscape. TJ explains how buying decisions have moved from physicians to complex committees, forcing reps to connect clinical outcomes with financial impact. He shares real world examples of breaking into major health systems like Cleveland Clinic, the importance of aligning sales and marketing, and how top performers build influence from both the ground up and top down. You will also learn how to create compelling value analysis briefs, generate demand in a post Covid world, and stand out in an increasingly competitive and crowded market. This episode is a must listen for anyone serious about mastering modern medical sales and closing high level deals.

Connect with TJ Quigley: LinkedIn

Connect with Me: LinkedIn

Love the show? Subscribe, rate, review, and share! Here’s How »

Listen on Spotify or Apple Podcast

Transcription:

Samuel Adeyinka (Host):
Hello and welcome to the Medical Sales Podcast. I’m your host, Samuel, the founder of a revolutionary medical sales training and mentorship program called the Medical Sales Career Builder. And I’m also host of the Medical Sales Podcast.

In this podcast, I interview top medical sales reps and leading medical sales executives across the entire world. It doesn’t matter what medical sales industry, from medical device to pharmaceutical to genetic testing and diagnostic lab. You name it. You will learn how to either break into the industry, be a top 10 percent performer within your role, or climb the corporate ladder.

Welcome to the Medical Sales Podcast. And remember, I am a medical sales expert sharing my own opinion about this amazing industry and how it can change your life.

Samuel Adeyinka (Host):
For people that don’t know about selling to doctors or trying to get into medical device, the days of features and benefits sales are over.

You really have to come in and drive into the value prop. How am I helping increase workflow. Am I reducing cost. Am I improving patient care. Whatever it is, I have to help the sales team build the message.

And it’s a two way street. It’s not me building the message with the team and sending it over the fence saying, good luck.

I have to be in the field with the salespeople to see what’s working. Because it might sound good in the office and then you get out there and it doesn’t resonate. And the customer looks at you like, what kind of BS are you trying to sell me.

TJ Quigley (Guest):
Let’s qualify that a little better, because I hear that a lot.

You said the days of features and benefits selling are over. Now it’s about value. What is the specific value proposition you’re trying to help me see. Give one example of how that has changed.

Samuel Adeyinka (Host):
The big shift happened around 2008 or 2009.

Before then, money was plentiful in healthcare. You could walk in and say, this is the newest feature, it has this laser, it has HD, whatever, and they would sign up.

Then money dried up. People realized we’re pumping money into healthcare and not getting returns. Hospitals started losing money and they looked hard at it.

At the same time, a lot of docs used to be sole proprietors. Now many are employees of the hospital.

So the docs are not the ones making decisions anymore. Nine times out of ten, if you bring a product over 5,000 dollars, it goes to an executive committee. The doc can’t just decide.

So you have to convince the doc, then give the doc data and information so they can present it. Because the committee doesn’t want us presenting it. They want the doc to explain why it matters.

And the committee’s goal is to put you in a box and lower the price as much as possible.

So if I come in with features and benefits, I’m not going to sell it. I have to find the value driver that moves the needle, so the bean counters can understand why it matters clinically.

That’s hard because the bean counters don’t understand clinical, and the doc doesn’t understand the business side. So we become intermediaries helping both sides speak the same language.

TJ Quigley (Guest):
That was gold. Crystal clear.

So it’s a multifaceted effort now. You have to hit multiple channels just to get a seat at the table.

Walk us through how your company makes that happen. What does the commercial team look like. Who’s doing what. How do you drive that.

Samuel Adeyinka (Host):
The sales rep is the first line of defense. They’re living and breathing on the hospital floor. ED, ICU, pediatrics, all of it.

Then marketing supports them with messaging, tools, collateral, presentations. That’s pushing from the bottom up.

But you also need top down. If it’s only the rep pushing up from the bottom, you might get activity, but you need corporate accounts teams too.

They build relationships above that executive committee level. They do quarterly business reviews. They walk through spend, performance, and the bigger picture.

I’ve seen an example where a rep was banging their head trying to get into Cleveland Clinic for years and nothing happened.

Then the corporate accounts person had a business review with their contact. The buyer did a double take.

What do you mean we’re spending 5 million with you. We had no idea.

Then the buyer asked, what else do you do. We said anesthesia, urology, multiple product lines. They didn’t know.

So we came in and did a product fair for that executive committee.

That two pronged approach matters. Bottom up with clinical support, top down with awareness and stakeholder relationships.

TJ Quigley (Guest):
Let’s stick with Cleveland Clinic.

How difficult was it to get the opportunity to show them they’re spending too much and need to make changes.

Samuel Adeyinka (Host):
Timing.

There was a new buyer. Sometimes that’s good, sometimes it’s not.

We were nervous because she had a reputation for being tough.

Marketing helped set up the deck and key messaging. We drove value, not features.

We delivered a half hour presentation and her jaw dropped at the 5 million. She had no idea.

At first we thought it was a bad reaction. But it opened the door.

And the 5 million was accurate. That was our internal spend data.

The issue is buyers don’t always see the full picture. Products are siloed. One buyer owns ortho, another owns surgical, another owns something else. They don’t always talk.

So when we showed the full pie, it created negotiation leverage. Now they can look for bulk deals and better terms.

TJ Quigley (Guest):
Who’s the ultimate decision maker in that scenario.

Samuel Adeyinka (Host):
Usually the buyer.

Sometimes there’s a “super buyer” overseeing multiple categories, but typically the buyer decides.

That’s why corporate accounts teams focus on those buyer relationships.

And buyers don’t like surprises.

If we only showed 600,000 and they later found out it was 5 million, it wouldn’t go well. Being upfront is the best approach.

TJ Quigley (Guest):
When you normally get the buyer’s attention, is it easy to close once you show them something like that. Is the hard part getting the meeting, or delivering a proposition that creates urgency.

Samuel Adeyinka (Host):
Both.

Getting the meeting is hard. If they don’t see value, they won’t meet.

But even if you get the meeting, you can still fail.

We’ve gone in with a value message and it fell flat. A buyer said, we don’t have leak rates here, so why are you pitching a product to reduce leak rates.

We left feeling like idiots.

So marketing went back to the data. We partnered with Definitive and started digging into accounts.

If we’re going to present a value differentiator, we need to know it’s real in that hospital.

And in systems, if you show success in one hospital, it can spread because buyers talk across facilities.

If you can show reduced length of stay for pneumonia patients, or improved efficiency, it can blow up across the system quickly.

TJ Quigley (Guest):
How did things change pre and post Covid when it comes to securing the meeting.

Samuel Adeyinka (Host):
They don’t want to see us. They never wanted to.

But post Covid is harder.

Now buyers manage multiple categories. They have thousands of SKUs. They don’t have time.

From a marketing perspective, one thing that’s been very helpful is a one pager leave behind. I call it a Value Analysis Brief.

You go in, they might only absorb 5 percent, then you leave. That brief stays on their desk.

It highlights the top three points. Here’s how it moves the needle. Here’s how it saves money. It keeps you top of mind.

We’ve also used small product boxes with the brief inside. Some hospitals still had the box on their desk four or five years later.

The key is insight.

Don’t walk in saying, our product saves thousands.

Walk in saying, I looked at your data. Your leak rates are high over the last three years. I think this can help. That’s a different conversation.

TJ Quigley (Guest):
So the leave behind gets attention and now they want the meeting.

Is that what’s been happening.

Samuel Adeyinka (Host):
It can be.

But it’s not just the rep dropping the leave behind. You also need clinical support.

If it’s only the rep pushing, your hit rate might be 20 percent, if you’re lucky.

You need champions. And champions aren’t always docs. They can be a nurse, a medical director, quality, nurse educator.

I’ve seen quality overhear a conversation about an ED initiative and say, wait, could this reduce length of stay for pneumonia patients. That became the deal driver.

One of the best field lessons I learned was from a rep in Chicago.

He said, you never know who you’ll run into in a hospital. If you enter and exit the same way every time, you won’t meet anyone new.

So he always went in one way and left another way. Next hospital, we ran into the exact doctor he’d been trying to reach for three months.

Consensus drives decisions now. Committees include nurses, docs, and finance. You need multiple people on board, because you don’t know who the real champion will be.

TJ Quigley (Guest):
So your marketing efforts are mostly field based movements. Sales uses the leave behind, finds the right champion, builds the right internal team, and closes the deal.

Samuel Adeyinka (Host):
That’s about half.

The other half is demand generation.

Shows and conventions are back, but traffic has not returned.

We’ll spend 200 to 300 thousand dollars and get 20 leads. That’s a problem.

So the onus is on marketing to drive traffic to the booth.

Not just getting more people to attend the conference, but getting the people who are there to come to your booth.

We tested tactics like sending 3D glasses, or creating a hidden path using special glasses and floor markers that guided attendees to the booth. That worked.

Coffee did not work. Half the time it was other vendors.

What worked was getting champions to speak. Not always docs. A nurse, educator, or operator sharing their success story and how it moved outcomes.

Also lunch or dinner symposiums linked to booth engagement. Stamp cards, check ins, those kinds of mechanics.

At the end of the day, sales has to drive field activity, and marketing has to make sure reps are getting leads.

Samuel Adeyinka (Host):
I hope you’re enjoying today’s episode. And remember, I have a customized and personalized program that gets you into the medical technology industry as a sales professional, or any type of role for that matter.

Become a top performer in your position and masterfully navigate your career to executive-level leadership. Check out these programs and learn more by visiting our site.

Fill out an application, schedule some time with one of our account executives, and allow us to get you where you need to be.

Stay tuned for more awesome content with amazing interviews on the Medical Sales Podcast.